Skip to content

Application and promotion of GnRHa combined with Sanjie Zhentong capsule in the long-term management of endometriosis

Application and promotion of GnRHa combined with Sanjie Zhentong capsule in the long-term management of endometriosis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027189
Enrollment
Unknown
Registered
2019-11-04
Start date
2020-12-21
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Women with stage III to IV of endometriosis confirmed by operation and received the conservative surgery; (2) women who were within 18-45 years old, (3) Women should be able to express their complaints and answers to symptoms in well mental and physical state. (4) No birth plan within one year; (5) Informed consent was signed;

Exclusion criteria

Exclusion criteria: (1) Patients who suffer gynecologic malignant tumor, genital tubercle, or those endometriosis patients who had underwent total hysterectomy with bilateral salpingo-oophorectomy; (2) Patients who suffer together with other internal diseases, like cardiovascular, hepatic, renal, or hematopoietic disease; (3) Combined with other gynecological endocrine diseases, such as PCOS; (4) Pregnancies or lactation; or patients who are allergic to the experimental drug; or those who have participated in other clinical trials; (5) Hb < 80g/L; (6) Patients with the family history of thrombosis or thrombotic disease. (7) Women with stage I to II of endometriosis confirmed by operation. (8) Patients with some other conditions that researchers considered unsuitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
VAS score;the MOS item short from health survey, SF-36;pelvic lesion;Recurrence Rate;

Secondary

MeasureTime frame
Ovarian Function;pregnancy rate;CA125;

Countries

China

Contacts

Public ContactCongjian Xu

Obstetrics and Gynecology Hospital of Fudan University

xucj@hotmail.com+86 13651796353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026